Brightmind.ai

brightmind.ai

Brightmind.AI is a neurotechnology company focused on developing personalized brain stimulation solutions for at-home use, primarily targeting migraine prevention. Their innovative approach leverages advanced research in transcranial magnetic stimulation to provide effective treatment options for the 80 million migraine sufferers in the US and Europe, with a reported reduction in migraine attacks by over 50% for up to 90% of users. The company aims to revolutionize brain health management by making their technology accessible in homes worldwide, addressing critical issues such as cognitive decline and depression. With a strong interdisciplinary team and significant funding support, Brightmind.AI is poised for growth in the Med Tech sector.